Control of acute myeloid leukemia and generation of immune memory in vivo using AMV564, a bivalent bispecific CD33 x CD3 T cell engager.

vixtimotamab (AMV564) - Affimed

http://www.ncbi.nlm.nih.gov/pubmed/38696390

Dilan A Patel; Feng Gao; John F DiPersio; Julie K Ritchey; Kiran Vij; Linda G Eissenberg; Michael P Rettig; Tae H Han; Victoria Smith

May 2, 2024